Medication evidence profile
Lumiracoxib
Clinical overview
Lumiracoxib has a public medication-list entry in CALS 2022 Table 4. This profile has one source version to examine, so a cross-scale comparison is not available from these rows.
Source-specific scores
| Source | Score |
|---|---|
| JARS | Not listed |
| Yamada-ABS | Not listed |
| BAAS | Not listed |
| Swe-ABS | Not listed |
| GABS | Not listed |
| KABS | Not listed |
| CALS | 1 |
How to read this: 0 means the source explicitly assigned zero. “Not listed” means the source did not provide a score for this medication. Scores from different scales are not averaged.
How to interpret the evidence
1 of 7 public source versions contain an explicit medication-list entry for lumiracoxib.
None of the public rows in this profile is an explicit zero. An unlisted source still supplies no value.
Source labels and provenance · 1 observation
- CALS 2022 - primary final Table 4
Source label: Lumiracoxib. Published value: 1.
Source version: CALS-2022-primary-table4
Source location: Table 4; literal capture row 87; displayed table row 13; displayed column 3
Observation: CALS2022_T4_0087; rating state: published_final_table_rating.
What this page does not establish
- No medication-list entry is available here from JARS 2025, Yamada-ABS 2023, BAAS 2019, Swe-ABS 2023, GABS 2018, and KABS 2020 open validation supplement. These gaps remain “Not listed”; no score is inferred from another source or from class membership.
- No route inference unless present in the source label.
- These source records do not estimate an individual’s probability of harm or establish whether to start, stop or change a medication. Ordinal source scores are not averaged into a UnifiedACB score.
References
- Ramos H, Moreno L, Pérez-Tur J, Cháfer-Pericás C, García-Lluch G, Pardo J. CRIDECO Anticholinergic Load Scale: an updated anticholinergic burden scale. Comparison with the ACB Scale in Spanish individuals with subjective memory complaints. J Pers Med. 2022;12(2):207. doi:10.3390/jpm12020207. Open source
Ask a follow-up
Go to your medication comparison · How UnifiedACB handles disagreement
Ask about this medication
Medication context: Lumiracoxib
Ask about this medication